Blood Clots: What They Are, Causes, Symptoms & Treatment
A blood clot is a lump of blood that can form in various body parts, including the legs, arms, lungs or heart. These clots can lead to severe health issues.This article will examine what blood clots are, their causes and symptoms. It’s important to no…
Learn MoreDOACs Reduce Dementia Risk Versus Warfarin in A-Fib
THURSDAY, Sept. 7, 2023 (HealthDay News) — For patients with atrial fibrillation (AF), the use of direct-acting oral anticoagulants (DOACs) significantly reduces dementia risk compared with warfarin, according to a systematic review and meta-analysis…
Learn MoreDOACs Reduce Dementia Risk Versus Warfarin in A-Fib
THURSDAY, Sept. 7, 2023 (HealthDay News) — For patients with atrial fibrillation (AF), the use of direct-acting oral anticoagulants (DOACs) significantly reduces dementia risk compared with warfarin, according to a systematic review and meta-analysis…
Learn MoreApixaban Has Lower Bleeding Risk for Initial Anticoagulation for Venous Thromboembolism
TUESDAY, Sept. 5, 2023 (HealthDay News) — Apixaban has a lower bleeding risk than warfarin or rivaroxaban during initial treatment for patients with venous thromboembolism (VTE), according to a study published online Aug. 28 in the Journal of Interna…
Learn MoreProlonged Direct Oral Anticoagulants Beneficial for Preventing Recurrent VTE
MONDAY, Aug. 21, 2023 (HealthDay News) — For patients with venous thromboembolism (VTE) continuing warfarin or direct oral anticoagulants (DOACs) beyond six months, the risk for recurrent VTE is lower with DOACs, according to a study published online…
Learn MoreTicagrelor-Acetylsalicylic Acid More Beneficial for Obese With Minor Stroke, TIA
MONDAY, July 10, 2023 (HealthDay News) — For patients with minor stroke or transient ischemic attack (TIA) who carry the CYP2C19 loss-of-function allele, those with obesity receive more clinical benefit from ticagrelor-acetylsalicylic acid (ASA) than…
Learn MoreAnticoagulants Do Not Reduce Arterial Thrombotic Event Risk in Cancer
FRIDAY, July 7, 2023 (HealthDay News) — For ambulatory patients on systemic anticancer therapy, anticoagulants do not reduce the risk of arterial thrombotic events (ATEs) and are associated with increased bleeding risk, according to a review publishe…
Learn MoreBenefits of Indefinite Anticoagulant Unclear After First VTE
THURSDAY, June 29, 2023 (HealthDay News) — For patients with a first unprovoked venous thromboembolism (VTE), indefinite anticoagulation prevents some recurrent VTE events but induces additional major bleeding events, according to a study published o…
Learn MoreCatheter-Directed Thrombolysis Beneficial for Pulmonary Embolism
TUESDAY, June 20, 2023 (HealthDay News) — For patients with intermediate- to high-risk pulmonary embolism, catheter-directed thrombolysis (CDT) is associated with a lower risk for death and major bleeding than systemic thrombolysis and with a lower r…
Learn MoreASCO: Direct Oral Anticoagulant Therapy Feasible for Cancer Patients
TUESDAY, June 6, 2023 (HealthDay News) — Direct oral anticoagulant (DOAC) treatment is noninferior to low-molecular-weight heparin (LMWH) for preventing recurrent venous thromboembolism (VTE) in cancer patients, according to a study published online …
Learn More